NP49426a Transition Medicines
The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · All their open notices
What this is
PSD Scotland (the Common Services Agency) is procuring the supply of Transition Medicines to NHS Scotland as a multi-lot framework worth an estimated GBP 61.8m excluding VAT: RSV immunisations, analgesics/anaesthetics & MSD generics, cardiovascular/respiratory/HIV, psychiatry & neurology, cancer medicines, and gastrointestinal/endocrine/nutrition/blood medicines. Lots are awarded as multi-supplier framework agreements per product line (Lot 1 unranked, others ranked), mostly starting 1 August 2026, with extension options. Run on PCS-Tender (project 31752).
Key points
- NHS Scotland transition-medicines framework, 6 therapeutic lots, GBP 61.8m est.
- Multi-supplier frameworks per product line (Lot 1 unranked, others ranked)
- Price 95% / supply chain 5% — a price play
- Deadline 22 June 2026 12:00 via PCS-Tender (project 31752)
- Serves all NHS (Scotland) Act bodies and Integrated Joint Boards
- Lot-specific durations and extension rights (up to 41 months on cancer medicines)
Who can bid
Open to pharmaceutical suppliers per the ITT on PCS-Tender (project 31752); bids may cover any or all of the 6 lots, awarded per product line.
How it is scored
Quality 5% · Price 95% Overwhelmingly price-driven: price 95% / supply chain 5% on every lot.
Money
Estimated GBP 61,847,781 ex VAT total; largest lots: cancer medicines GBP 43.1m, psychiatry & neurology GBP 12.6m, RSV immunisations GBP 6.1m.
How to submit
Via PCS-Tender by 22 June 2026 12:00 — express interest against project code 31752.
Clarifications
Through PCS-Tender messaging for project 31752.
Contract period
Lot-specific terms mostly starting 1 Aug 2026 (e.g. Lot 1 to Jul 2028, Lot 5 to Jan 2027), each with extension options up to 22-41 months.
Classification
CPV 33600000 — Pharmaceutical products Scotland
Published on Public Contracts Scotland. The official notice is the authoritative version.